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Abstract
Background: Evidence about the effectiveness of music therapy for improving the quality of life of palliative care
patients is positive but weak in terms of risk of bias.
Methods: This study aimed to determine the feasibility of a randomised controlled trial to evaluate the
effectiveness of music therapy for improving the quality of life of hospice inpatients, as measured by the McGill
Quality of Life questionnaire. Objectives included recruitment of 52 participants over 12 months and provision of
data to support the calculation of the required sample size for a definitive randomised trial, taking into account the
retention rates of recruited participants; and evaluation of the viability of the intervention and the acceptability of
the assessment tool. The design was a single-centre, researcher-blinded randomised pilot and feasibility study
involving two parallel groups. Participants were recruited from one inpatient hospice unit in Northern Ireland.
Eligibility criteria were an Eastern Cooperative Oncology Group performance status of two or lower and an
Abbreviated Mental Test score of seven or more. Consenting patients were randomly allocated to the intervention
or control group using a 1:1 allocation ratio. The intervention group received up to six individual music therapy
sessions over 3 weeks in addition to usual care. The control group received usual care only.
Results: Fifty one participants were recruited over 12 months. Twenty five were allocated to the intervention group
and 26 to the control group. Seventy one percent of participants were lost to follow up by week 3, the proposed
primary endpoint. The primary endpoint was moved from week 3, when 71% were lost to follow up to week 1,
when 33% were lost. The McGill Quality of Life questionnaire was generally acceptable to participants. In order to
detect a small to moderate effect size of 0.3, a fully powered study would require the recruitment of 698
participants.
Conclusions: A Phase III randomised controlled trial to evaluate the effectiveness of music therapy in improving
the quality of life of hospice inpatients is feasible.
Trial registration: ClinicalTrials.gov: NCT02791048. Registered 6 June 2016.
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Background
Music therapy is defined as the use of music and
sounds as part of a developing relationship between
the patient and therapist to support and improve
physical, mental and spiritual well-being [1]. At its
introduction to palliative care in the 1970s, music
therapy involved ‘receptive’ approaches where the pa-
tient could passively listen to music, and ‘recreative’
approaches where the patient could sing or play pre-
viously composed music [2–4]. Since then, it has de-
veloped to include improvisational music [5] and song
writing [6], both of which involve greater creative in-
put from the patient.
The effectiveness of music therapy in ameliorating a
wide range of psychological and physical problems asso-
ciated with palliative care has been reported in the lit-
erature [7]. This includes lowering levels of stress and
anxiety, and improving mood, relaxation, overall well-
being and attitude to life, along with reducing pain levels
[8–10]. However, while several studies have suggested
that music therapy may improve the quality of life of
palliative care patients, many of them had a high risk of
bias [10]. As a consequence, evidence about the effect-
iveness of music therapy for improving the quality of life
of palliative care patients remains equivocal and this is
an area of important uncertainty for the care of these
patients. It has been suggested that this lack of robust
evidence can at least partially explain why, while the
availability of music therapy for palliative and end-of-life
care patients is increasing, funding for it tends to be in-
consistent [11].
There are a number of practical considerations that
explain the lack of robust randomised trials in this
area. Firstly, there are inherent challenges, such as
high levels of attrition as a result of the deaths of
participants, to conducting randomised trials with pal-
liative care populations [12, 13]. Secondly, challenges
such as clinical gatekeepers’ lack of engagement with
what they may see as a marginal ‘complementary’
therapy present additional difficulties to those en-
gaging in experimental approaches to music therapy
research [14].
Aims and objectives
This study aimed to determine the feasibility of a rando-
mised controlled trial evaluating the potential effective-
ness of music therapy for improving the quality of life of
palliative care patients, and to pilot trial procedures. The
study objectives were to:
a. Provide data to support the calculation of the
required sample size for a definitive randomised
trial.
b. Evaluate the viability of delivering a 3 week music
therapy intervention, taking into account the
retention rates of recruited participants over that
period.
c. Evaluate the acceptability of administering the
McGill Quality of Life (MQoL) questionnaire to
this population [15].
d. Evaluate the potential effectiveness of music therapy
for improving quality of life.
e. Evaluate the potential effectiveness of music therapy
for improving inter-familial communication.
f. Identify factors that help or hinder the
implementation and sustainability of music therapy
within a hospice setting.
Only objectives a-d are reported on in this paper. Ob-
jectives e and f, which make up part of the critical realist
approach that is being taken to this evaluation [16], are
reported separately [17].
Methods
A more detailed explanation of the study’s procedures
can be found in our published protocol [18]. In the fol-
lowing, we include changes to the protocol in response
to interim findings.
Study design
This was a single-centre, researcher-blinded randomised
feasibility study involving two parallel groups. The inter-
vention group received individual music therapy in
addition to usual care. The control group received usual
care only.
Randomization and masking
Consenting patients were randomly allocated to the
intervention or control group using a 1:1 allocation ra-
tio. An independent statistician conducted blocked
randomization with randomly permuted block sizes,
which was used to fill opaque randomization envelopes.
These were stored in the clinical investigator’s locked fil-
ing cabinet at the hospice and used in sequence, thereby
ensuring allocation concealment up to the point of
randomization. To maintain researcher blinding, the
treatment allocation was forwarded directly to the music
therapist by the clinical investigator.
Setting
Participants were recruited from an 18-bed specialist
palliative care unit in a hospice in Northern Ireland.
Participants
Patients were screened upon admission to the inpatient
hospice unit by the clinical investigator. If they were
deemed to have sufficient physical and mental capacity
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to take part (Eastern Cooperative Oncology Group
(ECOG) performance status [19] of two or lower; Abbre-
viated Mental Test (AMT) Score [20] of seven or
more), the clinical investigator provided them with in-
formation about the trial, including the participant in-
formation sheet. If they consented, she referred them
to the researcher for potential recruitment. If, follow-
ing further discussion with the researcher, the patient
consented to participate, they were asked to sign an
informed consent form. The researcher then informed
the clinical investigator. Once recruited, the clinical
investigator allocated patients to groups by opening
the opaque envelopes in sequence.
After the first month, we recognised that recruit-
ment was lower than expected. Clinical advice indi-
cated that patients having an ECOG performance
status that was worse than the initial exclusion
threshold would still be capable of participating in
the study, and might benefit from doing so. We
therefore amended the protocol to include patients
with an ECOG performance status of three or lower.
Intervention
Patients were randomly assigned to two groups. The
control group received usual care, as deemed appro-
priate by the multidisciplinary hospice team. The ex-
perimental group received music therapy in an
individual setting, delivered by a trained and regis-
tered music therapist, in addition to usual care.
A person-centred and creative music therapy approach
which employed a systematic therapeutic process that
included assessment, therapy and evaluation was
adopted, guided by each patient’s needs, interests, prefer-
ences and energy levels, and adapted accordingly in the
moment [21]. During sessions, an interactive music
therapeutic approach was used, whereby the client
would engage by singing, playing or listening to known
music, or extemporaneously create a melody, rhythm,
song or instrumental piece with the therapist’s support.
The specific approach used in sessions was agreed with
each participant.
Patients could choose to have a carer or significant
other present during the intervention. If patients and
carers wished, carers could be actively involved in the
music therapy sessions.
Music therapy was conducted for up to 45 min
twice a week over 3 weeks. In addition to standard
clinical documentation, the music therapist completed
an intervention manual [22] at the end of each ses-
sion, including details on who chose the music and
what strategy was used from the available suite of
music therapy interventions (such as music listening,
active music-making, improvising, and legacy work).
Quantitative research instrument
We used the McGill Quality of Life Questionnaire
(MQoL) [15], which has been reported to have the best
clinimetric quality rating, content validity, construct val-
idity and internal consistency in a review of quality of
life questionnaires for use in palliative care [23]. The
MQoL is a 16 item questionnaire which is divided into
five sub-measures with a varying number of questions
for each sub-measure. The sub-measures are physical
symptoms (3 questions), physical well-being (1), psycho-
logic well-being (4), existential well-being (6), and sup-
port (2), with each question being scored from zero to
ten by the patient. The final score is calculated as one
fifth of the mean of the mean scores from each
sub-measure. The higher the score, the better the quality
of life of the patient and it has been suggested that a dif-
ference of 1 to 2 points in the overall score is equivalent
to the difference between an average and a good day,
and between a bad and an average day [24].
We also collected self-reported baseline data on the
patients, including age, gender, ethnicity, marital status
and their use of complementary therapies.
Analysis of outcomes
a. The capacity to recruit 52 patients to the study in a
recruitment period of 12 months and to retain 70%
of these to completion was recorded. 52
participants is a third more than the minimum
recommended for good practice in a feasibility
study [25] and a 30% attrition allowance is
recommended for a palliative care population [26].
These figures, along with input from practitioners
and carers on what would be a clinically meaningful
difference, were then used to support the
calculation of the required sample size for a
definitive RCT.
b. The viability of delivering a 3 week music therapy
intervention was determined by attrition figures
along with reasons for attrition.
c. The acceptability of the MQoL questionnaire was
evaluated at each data collection point by the
researcher, who requested verbal feedback from all
patients in relation to the acceptability of the
questionnaire’s content and level of burden to
complete. This verbal feedback was recorded and
thematically analysed for any patterns in relation to
acceptability. We also monitored and analysed the
number of completed questionnaires along with
reasons for non-completion using descriptive
statistics.
d. Our initial intention was to assess potential
effectiveness by determining the change over time in
the MQoL, which was to be measured at baseline, at
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3 weeks (i.e. after completion of music therapy) and 5
weeks (i.e. 2 weeks after completion of music
therapy). However, it became apparent that many
patients were not surviving long enough after
recruitment to reach the 3 week time point and we
therefore instigated a MQoL follow-up at 1 week,
making the change from baseline to this time point
the primary outcome for the effectiveness assessment
in this feasibility study. In the protocol, we had envis-
aged using analysis of covariance to compare the
change in quality of life outcomes between the two
randomised groups over time. However, for simplicity
and given the high attrition rates beyond the first
week, we report here the unadjusted mean differences
between the groups for the change from baseline to
week 1. Results are shown with their associated
standard deviations (SD) or 95% confidence intervals
(CI). In the absence of a formal power calculation, we
advise caution when interpreting our results.
Reporting
The reporting of this study follows the CONSORT ex-
tensions for abstracts and for pilot and feasibility trials.
Monitoring adverse events
A Serious adverse events (SAE) form was included in
each patient’s case report form. As per protocol, any
SAE was to be reported to the Principle Investigator
within 24 h, and reviewed by the Trial Steering Commit-
tee (TSC) at regular intervals throughout the trial. No
adverse events were reported during the trial.
Ethics approval and consent to participate
Ethical approval was provided from the Office of Re-
search Ethics Committee Northern Ireland (ORECNI)
(reference number 16/NI/0058), which also provided ap-
proval for alterations to the protocol made during the
study. Patients and staff provided written informed con-
sent prior to participation in the study.
Results
Recruitment, retention and sample size calculation
We recruited and randomised 51 patients between June
2016 and June 2017 (the predesignated time point for
ending recruitment), which was 98% of the original tar-
get of 52 participants. 43.2% of 118 patients deemed eli-
gible for the study were recruited. Reasons for
non-recruitment included those who declined (n = 28),
early discharge (n = 12), non-availability of music therap-
ist due to sickness/annual leave (n = 24), and music ther-
apist at full capacity (n = 2).
One patient did not complete the baseline MQoL. The
first nine patients (music therapy: 4; control: 5) were re-
cruited before we introduced the outcome measurement
at week 1. The attrition rate for the week 1 outcome in
the other 42 patients was 33%. The attrition rates were
much higher for outcome measurement at week 3 (71%
of 51 patients) and week 5 (92% of 51 patients), primar-
ily due to the death of the patient or because they were
too unwell to complete the MQoL.
Loss to follow-up
We compared the baseline MQoL data for patients who
did and did not complete the MQoL at week 1, to ex-
plore any differences between patients who were
retained and those who were lost. Visual inspection of
the data showed no differences between the randomised
groups in the MQoL as a whole or within any of its
sub-measures. Reasons for loss to follow-up are shown
in the Consort Flow Diagram (Fig. 1). Table 1 shows the
baseline characteristics of the randomised patients.
On the basis of data derived from self-assessed phys-
ical wellbeing at baseline, there was little evidence that
the lowering of the ECOG score threshold to render pa-
tients who were less well eligible for recruitment led to a
notable increase in attrition rates. There was no signifi-
cant correlation between initial rating of physical well-
being and likelihood of completion.
Sample size calculation
The difference in improvement between the groups was
non-significantly in favour of music therapy: 0.30 (95%
CI: - 0.45 to 1.05, p = 0.43). Based on a two sample
t-test, a sample size of 470 (235 per group) will have
90% power at a two-tailed significance level of 0.05 to
detect a mean difference of 0.3 (pooled standard devi-
ation = 1) between groups, representing a small to
medium effect size. Taking account of an attrition rate
of 33%, a fully powered study would be required to re-
cruit 351 participants per group (see Table 2).
Viability of three-week intervention
The study protocol included a plan to recruit from
hospice inpatients and outpatients. However, organisa-
tional difficulties relating to facilitating outpatients to
attend music therapy sessions led to a decision to re-
cruit exclusively from inpatients. One of the conse-
quences of this decision was that the average life
expectancy of potential participants was considerably
reduced. This was reflected in the afore-mentioned
high attrition rates at three and 5 week’s follow-up.
This attrition was problematic in relation to thera-
peutic intent, given that so many patients did not re-
ceive the intended dosage of the music therapy, and
in assessing the effects of the therapy beyond the first
week. We therefore concluded that a three-week
intervention was not viable and, as noted above, that
the primary outcome should be measured after 1
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Fig. 1 Patient flow through the study
Table 1 Baseline characteristics of the randomised patients
Music therapy (a) Control (a) Total (a) Music therapy (b) Control (b) Total (b)
Gender
Female [n (%)] 20 (80%) 16 (62%) 36 (71%) 16 (76%) 13 (62%) 29 (69%)
Male [n (%)] 5 (20%) 10 (38%) 15 (29%) 5 (31%) 8 (38%) 13 (31%)
Age (years) [mean (SD)] 63 (11.1) 70.7 (10.2) 66.9 (11.2) 63.9 (11.0) 71.3 (10.5) 67.6 (11.3)
Ethnicity
White [n (%)] 25 (100%) 26 (100%) 51 (100%) 21 (100%) 21 (100%) 51 (100%)
Marital status (missing for one
control patient)
Single [n (%)] 4 (16%) 3 (12%) 7 (14%) 3 (%) 2 (%) 5 (%)
Married/with partner [n (%)] 15 (60%) 15 (58%) 30 (59%) 12 (%) 14 (%) 26 (%)
Divorced [n (%)] 6 (24%) 2 (8%) 8 (16%) 6 (%) 1 (%) 7 (%)
Widowed [n (%)] 0 (0%) 5 (19%) 5 (10%) 0 (0%) 3 (%) 3 (%)
User of other complementary
therapies [n (%)]
17 (68%) 10 (38%) 27 (53%) 14 (67%) 7 (33%) 21 (50%)
Baseline MQoLMQoL [mean (SD)] 6.1 (1.2) 6.0a (1.4) 6.1a (1.3) 6.0 (1.3) 6.1a (1.4) 6.0a (1.3)
(a) All 51 recruited patients; (b) 42 patients recruited after introduction of MQoLMQoL at week 1
aExcludes one patient who did not complete the baseline MQoLMQ
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week. This decision was supported by evidence that a
one-week intervention had the potential to be thera-
peutically effective [27, 28]. Therefore, with approval
from the Research Ethics Committee, we amended
the protocol during the study to include an additional
and earlier follow-up visit after 1 week (after one to
two sessions of music therapy) to assess which
time-frame is most feasible for an inpatient popula-
tion at an advanced stage of their illness.
Acceptability of MQoL questionnaire
Feedback from participants on the acceptability of the
MQoL questionnaire was encouraging. Only two par-
ticipants questioned the pertinence of the information
being requested. In terms of burden, only one partici-
pant declined to fill out the baseline questionnaire
(6% overall). Two patients withdrew from the study.
The main issue of concern was the burden that
follow-up administration of the questionnaire placed
on participants, given the number of people identified
who did not fill out questionnaires at follow-up be-
cause they were too ill.
Potential effectiveness
As expected in a feasibility study, the change from
baseline to week 1 was not statistically significantly
different between the music therapy and the control
group. Among the patients who completed both the
baseline MQoL and the MQoL at week 1, those in
the intervention group (n = 15) showed a mean im-
provement of 0.5 points (SD: 0.9), while those in the
control group (n = 13) showed a mean improvement
of 0.2 points (SD: 1.1). The difference between the
groups was non-significantly in favour of music ther-
apy: 0.30 (95% CI: -0.45 to 1.05, p = 0.43). Table 2
shows the overall results and the results for the
sub-measures in the MQoL. Although most of these
are not significantly different between the randomised
groups, there was a notable improvement in existen-
tial well-being for the music therapy group compared
to the control group, and a notable disimprovement
in significant disimprovement in physical well-being.
However, as noted above these results needs to be
interpreted with care and do not provide definitive
evidence of a benefit or harm for music therapy in
these aspects of patient well-being.
Discussion
Recruitment, retention and sample size calculation
While the target sample size was almost attained, the
study identified a significant inhibitor to successful
recruitment – the unavailability of a music therapist
to carry out the intervention, which accounted for
39.4% of those deemed eligible for participation but
not recruited. This indicates the need in any future
trials for the logistical capacity of music therapy
provision to be sufficiently robust to ensure that it is
available to all participants who consent and who are
randomly allocated to the intervention arm.
The study also identified major problems in relation to
retention, with 71% of patients being lost to follow up at
week 3 and 92% at week 5; an attrition rate due over-
whelmingly to their death or physical deterioration.
Clearly, such retention rates indicate that an RCT based
on these follow-up time points would not be feasible. In
contrast, the attrition rate at week 1 was 33%, marginally
above the attrition rate pre-estimation of 30%.
When considered in the context of recruitment
rates in this study, the calculation that a
fully-powered study would require the recruitment of
702 participants indicates the need for a multi-centre
study that includes larger sites. The pilot study re-
cruited 51 participants over 12 months in an 18 bed
hospice. However, 26 non-recruitments were due to
lack of music therapy resources, which in turn were
due to limited funding for the study. A conservative
assumption that 50% of those not recruited due to
lack of music therapy resources could have been re-
cruited if the adequate resources had been available
gives a recruitment estimate of 64 participants per 18
beds per year. We therefore estimate that with access
to sites with a total number of 100 beds, and with
sufficient resources to ensure the consistent availabil-
ity of music therapists, the sample size could be
achieved over a recruitment period of 24 months.
Table 2 Change from baseline to week 1 in MQoL and sub-measures
Baseline MQoL, overall and sub-measures [mean, (SD)] Music therapy (n = 15) Control (n = 13) Mean difference (95% CI)
MQoL overall 0.5 (0.9) 0.2 (1.1) 0.30 (− 0.45, 1.05)
Physical symptoms 1.5 (2.6) 0.4 (3.5) 1.10 (−1.21, 3.41)
Physical well-being −2.2 (3.8) −0.2 (3.4) − 2.00 (−4.67, 0.67)
Psychologic well-being 1.0 (1.6) 0.4 (2.3) 0.60 (−0.89, 2.09)
Existential well-being 1.7 (1.5) 0.0 (2.5) 1.70 (0.14, 3.26)
Support 0.4 (1.9) 0.3 (3.7) 0.10 (−2.13, 2.33)
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Viability of intervention
As noted above, the attrition rates recorded in this study
indicate that a three-week intervention is not viable, but
a one-week intervention is. However, while the partici-
pating music therapists concurred that a one-week inter-
vention consisting of two music therapy sessions was a
viable and potentially effective dosage, they reported that
much of the first session offered was taken up with
introducing the participants to music therapy, the music
therapist, and to deciding what mode of music therapy
would be most appropriate to their needs. This limited
the time available for active therapy. This suggests that
the most appropriate regimen would involve three ses-
sions in a week, the first being primarily concerned with
introductory activities. While the feasibility of this regi-
men was not tested in the pilot study, the palliative care
clinicians and music therapists involved in the study
concurred that, on balance, the extra burden to partici-
pants that an extra session involved (which they did not
deem to be heavy) would be outweighed by the potential
improvement in the effectiveness of the intervention.
The acceptability of administering the MQoL
questionnaire
The main issue in relation to the acceptability of admin-
istering the questionnaire related to the fact that 12 out
of the 14 patients lost to follow-up at week 1 withdrew
because they were too ill to continue and therefore did
not complete the follow-up questionnaire. However,
given the clinical profile of the patient population in-
volved in this study, this was expected (although the ac-
tual attrition rate was 10% higher than the pre-estimated
rate). Given their physical deterioration, we do not be-
lieve that administering a shorter questionnaire would
have had any significant impact on the number of pa-
tients completing. Given that the questionnaire was ac-
ceptable to the overwhelming majority of participants at
baseline, we conclude that the MQoL is an acceptable
instrument to use.
Potential effectiveness
While the study showed a non-statistically significant
improvement of the overall scores from baseline to week
1 of the music therapy group compared to the control
group, that outcome was the result of the aggregation of
divergent scores for the individual domains, ranging
from a significant improvement in existential well-being
to a significant disimprovement in physical well-being.
This disimprovement was a surprising result, not least
because the closely related domain of physical symptoms
showed a strong improvement. Moreover, a recent sys-
tematic review suggested that music therapy may be ef-
fective in helping to reduce pain in palliative care
patients [10]. Nor have we been able to intuit any
putative mechanisms by which music therapy might
cause such a response. However, notwithstanding the
need to treat this result with caution because of the size
of the pilot study, it cannot be ignored. It is therefore
important that any future, fully powered study should
include both the overall quality of life result and the re-
sults of the individual domains as outcomes. Returning
to the issue of the burden of the questionnaire, this con-
clusion underlines the importance of administering the
complete questionnaire, rather than ‘cherry-picking’
those domains where improvement might be expected.
Strengths and weaknesses
The key strength of this study was its ability to demon-
strate, in light of the well-documented difficulties of
recruiting to music therapy research and the inherent
problems of conducting research with a palliative care
population, that a large-scale RCT to evaluate the effect-
iveness of music therapy in palliative care is feasible.
It also clearly demonstrated the weaknesses of the ori-
ginal protocol, most significantly in relation to recruit-
ment and retention. In relation to recruitment, it
demonstrated the importance of having sufficient human
resources to ensure that everyone who consented to par-
ticipate would be given the intervention if they were al-
located to that group. The crucial role that resources
play indicates the need for any future trial to incorporate
a robust health economic analysis to ascertain the
cost-effectiveness of music therapy compared to stand-
ard care.
In terms of retention, the large numbers lost to
follow-up at week 3 and beyond demonstrated that a sin-
gle week intervention, along with the administration of
the MQoL at Day 7 after its baseline administration, was
the only viable option. However, the use of a 7 day end
point for data gathering, while enabling sufficiently pow-
ered analysis, would tell us nothing about whether or not
music therapy was effective in improving the quality of life
of surviving participants in the days and weeks after that
point. It is therefore important that a future trial should
incorporate evaluation of longer term effects. The diffi-
culty with doing so is the already identified problem of at-
trition in this patient population, which rose to 71% at 3
weeks, making any statistically significant evaluation of ef-
fectiveness at this point unlikely. We therefore propose a
compromise endpoint of 14 days at which time the MQoL
should be re-administered to consenting patients. This
should be supplemented by qualitative data to illuminate
the experiences of participants and their close others.
Conclusions
This study has demonstrated the feasibility of conduct-
ing a Phase III RCT to evaluate the effectiveness of
music therapy in improving the quality of life of
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palliative care patients in an inpatient hospice setting.
We recommend that the next step for future research is
to perform a fully powered trial using a revised protocol
that takes into account the findings of this study. We
recommend that the primary outcome of the trial should
be the difference in change of MQoL from baseline to Day
7 between patient participants who received standard care
with music therapy and those who received standard care
alone. A secondary outcome should be the difference in
change of MQoL between baseline and Day 14.
Robust findings from that trial would make a signifi-
cant contribution to an evidence base that currently pro-
vides commissioners of palliative care services and
therapies with equivocal information upon which to base
their judgements about the inclusion or otherwise of
music therapy in the palliative care armamentarium.
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